Document is current
Any future updates will be listed below
-
Authors
Marchak, Jordan Gilleland https://orcid.org/0000-0002-8747-7375
Cherven, Brooke
Williamson Lewis, Rebecca
Edwards, Paula
Meacham, Lillian R.
Palgon, Michael
Escoffery, Cam
Mertens, Ann C.
-
Funding
Funding for this research was provided by:
National Cancer Institute of the National Institutes of Health (R01CA218389)
Agency for Healthcare Research and Quality (R18 HS017831-01)
Lance Armstrong Foundation (n/a)
CURE Childhood Cancer, Inc. (n/a)
- License Information
-
More Information
Article History
Received: 22 August 2019
Accepted: 20 November 2019
First Online: 18 December 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.
: The research conducted to develop and evaluate Cancer SurvivorLink<sup>TM</sup> was evaluated by Emory University’s institutional review board (IRB) and determined to be exempt from IRB review. Emory University’s IRB granted a HIPAA authorization waiver to cover the identification and contact of eligible participants for the needs assessment and usability evaluations.
: The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies.
